RFS | ||||||
---|---|---|---|---|---|---|
Univariate analysis | Multivariate analysis | |||||
HR | 95% CI | p value | HR | 95% CI | p value | |
Age (≥ 66 vs. < 66) | 1.489 | 0.620–3.576 | 0.373 | |||
Gender (Male vs. female) | 0.559 | 0.235–1.331 | 0.189 | |||
Tumor size at diagnosis (> 2 cm vs. ≤ 2 cm) | 0.835 | 0.322–2.170 | 0.712 | |||
NAT (yes vs. no) | 0.952 | 0.400–2.269 | 0.912 | |||
Radiation (yes vs no) | 0.365 | 0.048–2.755 | 0.329 | |||
CA 19-9 (> 37 U/ml vs. ≤ 37 U/ml) | 1.780 | 0.717–4.417 | 0.214 | |||
DUPAN-2 (> 150 U/ml vs. ≤ 150 U/ml) | 2.201 | 0.931–5.204 | 0.073 | |||
Pathological surgical margin (positive vs. negative) | 0.762 | 0.295–1.969 | 0.575 | |||
Pathological surgical margin (≤ 1 mm vs. > 1 mm) | 0.686 | 0.287–1.641 | 0.397 | |||
Molecular surgical margin (positive vs. negative) | 3.989 | 1.569–10.14 | 0.004 | 3.522 | 1.352–9.179 | 0.010 |
CY (positive vs. negative) | 0.767 | 0.177–3.320 | 0.722 | |||
n (positive vs. negative) | 0.275 | 0.037–2.048 | 0.207 | |||
ly (positive vs. negative) | 2.706 | 0.986–7.425 | 0.053 | |||
v (positive vs. negative) | 2.841 | 1.178–6.848 | 0.020 | 2.323 | 0.936–5.769 | 0.069 |
s (positive vs. negative) | 1.672 | 0.558–5.012 | 0.359 | |||
rp (positive vs. negative) | 1.876 | 0.630–5.590 | 0.259 | |||
ch (positive vs. negative) | 1.735 | 0.718–4.196 | 0.221 | |||
du (positive vs. negative) | 1.249 | 0.525–2.972 | 0.615 | |||
pv (positive vs. negative) | 0.876 | 0.351–2.188 | 0.777 |